Cargando…

The antiphospholipid antibody syndrome: a case report

Antiphospholipid antibody syndrome is defined by the presence of thromboembolic complications and/or pregnancy morbidity in the presence of persistently increased titers of antiphospholipid antibodies. Its clinical presentation can be diverse and any organ can be involved, with a current impact in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Luma, Henry Namme, Doualla, Marie-Solange, Temfack, Elvis, Bagnaka, Servais Albert Fiacre Eloumou, Mankaa, Emmanuella Wankie, Fofung, Dobgima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658257/
https://www.ncbi.nlm.nih.gov/pubmed/23754926
http://dx.doi.org/10.2147/IMCRJ.S36129
_version_ 1782270241528610816
author Luma, Henry Namme
Doualla, Marie-Solange
Temfack, Elvis
Bagnaka, Servais Albert Fiacre Eloumou
Mankaa, Emmanuella Wankie
Fofung, Dobgima
author_facet Luma, Henry Namme
Doualla, Marie-Solange
Temfack, Elvis
Bagnaka, Servais Albert Fiacre Eloumou
Mankaa, Emmanuella Wankie
Fofung, Dobgima
author_sort Luma, Henry Namme
collection PubMed
description Antiphospholipid antibody syndrome is defined by the presence of thromboembolic complications and/or pregnancy morbidity in the presence of persistently increased titers of antiphospholipid antibodies. Its clinical presentation can be diverse and any organ can be involved, with a current impact in most surgical and medical specialties. The authors present the case of a 43-year-old man who, over a 13-year period of follow-up, presented with thrombosis of the mesenteric vein, inferior vena cava, and axillary and subclavian veins in a setting where diagnostic and therapeutic options are limited and costly. Through this case report, the authors aim to describe the evolution of this complex pathology, which to date has not been described in the authors’ milieu – probably because of its challenging diagnosis and the limited treatment options available. The authors conclude that clinicians need to have a high index of suspicion of APS in patients who present with a thrombotic episode – clinicians should investigate for the presence of antiphospholipid antibodies, as early diagnosis may influence the course of the disease. Furthermore, resources for the detection of antiphospholipid antibodies should be made readily available in resource-limited settings. Finally, patient education on the importance of drug compliance, periodic monitoring, and prevention of thrombosis is indispensable, especially as mortality could be associated with the effects of vascular thrombosis and/or the effects of bleeding due to anticoagulants.
format Online
Article
Text
id pubmed-3658257
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-36582572013-06-10 The antiphospholipid antibody syndrome: a case report Luma, Henry Namme Doualla, Marie-Solange Temfack, Elvis Bagnaka, Servais Albert Fiacre Eloumou Mankaa, Emmanuella Wankie Fofung, Dobgima Int Med Case Rep J Case Report Antiphospholipid antibody syndrome is defined by the presence of thromboembolic complications and/or pregnancy morbidity in the presence of persistently increased titers of antiphospholipid antibodies. Its clinical presentation can be diverse and any organ can be involved, with a current impact in most surgical and medical specialties. The authors present the case of a 43-year-old man who, over a 13-year period of follow-up, presented with thrombosis of the mesenteric vein, inferior vena cava, and axillary and subclavian veins in a setting where diagnostic and therapeutic options are limited and costly. Through this case report, the authors aim to describe the evolution of this complex pathology, which to date has not been described in the authors’ milieu – probably because of its challenging diagnosis and the limited treatment options available. The authors conclude that clinicians need to have a high index of suspicion of APS in patients who present with a thrombotic episode – clinicians should investigate for the presence of antiphospholipid antibodies, as early diagnosis may influence the course of the disease. Furthermore, resources for the detection of antiphospholipid antibodies should be made readily available in resource-limited settings. Finally, patient education on the importance of drug compliance, periodic monitoring, and prevention of thrombosis is indispensable, especially as mortality could be associated with the effects of vascular thrombosis and/or the effects of bleeding due to anticoagulants. Dove Medical Press 2012-10-05 /pmc/articles/PMC3658257/ /pubmed/23754926 http://dx.doi.org/10.2147/IMCRJ.S36129 Text en © 2012 Luma et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Case Report
Luma, Henry Namme
Doualla, Marie-Solange
Temfack, Elvis
Bagnaka, Servais Albert Fiacre Eloumou
Mankaa, Emmanuella Wankie
Fofung, Dobgima
The antiphospholipid antibody syndrome: a case report
title The antiphospholipid antibody syndrome: a case report
title_full The antiphospholipid antibody syndrome: a case report
title_fullStr The antiphospholipid antibody syndrome: a case report
title_full_unstemmed The antiphospholipid antibody syndrome: a case report
title_short The antiphospholipid antibody syndrome: a case report
title_sort antiphospholipid antibody syndrome: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658257/
https://www.ncbi.nlm.nih.gov/pubmed/23754926
http://dx.doi.org/10.2147/IMCRJ.S36129
work_keys_str_mv AT lumahenrynamme theantiphospholipidantibodysyndromeacasereport
AT douallamariesolange theantiphospholipidantibodysyndromeacasereport
AT temfackelvis theantiphospholipidantibodysyndromeacasereport
AT bagnakaservaisalbertfiacreeloumou theantiphospholipidantibodysyndromeacasereport
AT mankaaemmanuellawankie theantiphospholipidantibodysyndromeacasereport
AT fofungdobgima theantiphospholipidantibodysyndromeacasereport
AT lumahenrynamme antiphospholipidantibodysyndromeacasereport
AT douallamariesolange antiphospholipidantibodysyndromeacasereport
AT temfackelvis antiphospholipidantibodysyndromeacasereport
AT bagnakaservaisalbertfiacreeloumou antiphospholipidantibodysyndromeacasereport
AT mankaaemmanuellawankie antiphospholipidantibodysyndromeacasereport
AT fofungdobgima antiphospholipidantibodysyndromeacasereport